Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
14,056,265
-
Share change
-
+2,593,559
-
Total reported value
-
$582,204,548
-
Put/Call ratio
-
106%
-
Price per share
-
$41.42
-
Number of holders
-
105
-
Value change
-
+$105,808,809
-
Number of buys
-
75
-
Number of sells
-
32
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q2 2020
As of 30 Jun 2020 Krystal Biotech, Inc. - COMMON STOCK (KRYS) had 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,056,265 shares of stock of the company.
Largest 10 holders included Redmile Group, LLC, FMR LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FRAZIER MANAGEMENT LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, STATE STREET CORP, CREDIT SUISSE AG/, and Point72 Asset Management, L.P..
This table shows 105 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.